About Jenburkt
Jenburkt is a company based in Mumbai (India) founded in 1985 by Harshad Bhuta, Hemendra Bhuta, and Uttam Bhuta. The company has 779 employees as of March 31, 2024. Jenburkt offers products and services including Favivent and Nutraceuticals.
- Headquarter Mumbai, India
- Employees 779 as on 31 Mar, 2024
- Founders Harshad Bhuta, Hemendra Bhuta, Uttam Bhuta
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Jenburkt Pharmaceuticals Ltd
-
Annual Revenue
$17.79 M (USD)6.85as on Mar 31, 2025
-
Net Profit
$3.75 M (USD)23.42as on Mar 31, 2025
-
EBITDA
$4.83 M (USD)22.34as on Mar 31, 2025
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
779
as on Mar 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Jenburkt
Jenburkt is a publicly listed company on the BSE with ticker symbol JENBURPH in India, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Jenburkt
Jenburkt offers a comprehensive portfolio of products and services, including Favivent and Nutraceuticals.
Favivent is offered as a prescription medication for COVID-19 treatment under accelerated approval, where it is administered under medical supervision for effective outcomes.
Nutraceuticals are provided in various therapeutic areas, where they are designed to support health outcomes through quality formulations accessible worldwide.
Funding Insights of Jenburkt
Detailed funding history for Jenburkt
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Jenburkt
Investment portfolio details for Jenburkt
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Jenburkt
Detailed financials for Jenburkt
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Jenburkt Comparisons
Peer comparison for Jenburkt
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Jenburkt
Detailed competitors of Jenburkt
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Jenburkt
Complete news archive for Jenburkt
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Jenburkt
Jenburkt was founded in 1985.
Jenburkt is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
As of Mar 31, 2024, the latest employee count at Jenburkt is 779.
Annual revenue of Jenburkt is $17.79M as on Mar 31, 2025.
Jenburkt was founded in 1985 in Mumbai, India, within the pharmaceutical sector. Formulations and prescription medications are produced across areas like pain management, anti-infectives, and consumer products. A WHO-GMP approved facility is utilized for manufacturing, alongside a dedicated RD unit for healthcare innovations. Distribution occurs both domestically and internationally.
Jenburkt offers Favivent and Nutraceuticals.
Yes, Jenburkt is publicly traded on BSE under the ticker symbol JENBURPH.
The ticker symbol of Jenburkt is JENBURPH on BSE.